<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162679" disease_type="Neoplastic Process" abbrv="">Leukemic infiltration</z:e> of the gingiva is most commonly reported to be associated with monocytic subtypes of <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) but rarely with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report a case of CD56+ <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) who developed gingival involvement simultaneously when the leukocyte count elevated </plain></SENT>
<SENT sid="2" pm="."><plain>At that time no increase in peripheral or bone marrow blasts were observed </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000212'>Gingival hypertrophy</z:hpo> regressed with the treatment of <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Three months later, bone marrow blast count elevated and the patient was treated with two courses of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-like regimen and then one course of consolidation therapy </plain></SENT>
<SENT sid="5" pm="."><plain>The patient is in complete hematological remission for one and a half years </plain></SENT>
<SENT sid="6" pm="."><plain>Similar to other extramedullary involvements, <z:hpo ids='HP_0000212'>gingival hypertrophy</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> can be a harbinger of the disease entering a more aggressive phase requiring systemic chemotherapy </plain></SENT>
</text></document>